AMARNA THERAPEUTICS
Based on its unique properties SVac is ideally suited for developing next generation effective gene and immune-therapies. In order to realize our ambition to become the leading global gene therapy company they formed a worldwide consortium of key players in the virology, vector production, immunology, ophthalmology, oncology, neurology and gene therapy fields of research. With major regulatory, legal and intellectual property firms, they are developing a range of innovative and effective interventions for genetic disorders, degenerative diseases, allergies and cancer. Interventions that will dramatically improve patients’ life expectancy and quality and moreover will significantly reduce the health care costs of the society in general.
AMARNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.amarnatherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M EUR
Technology used in webpage:
ReCAPTCHA Google Maps API Google Maps For Work German Server Location
Similar Organizations
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Human stem cells institute PJSC
Human stem cells institute PJSC is a privately held company operates as a biotech company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Eurostars
Eurostars investment in Grant - Amarna Therapeutics
Flerie Invest
Flerie Invest investment in Venture Round - Amarna Therapeutics
C4 Ventures
C4 Ventures investment in Venture Round - Amarna Therapeutics
Netherlands Enterprise Agency
Netherlands Enterprise Agency investment in Debt Financing - Amarna Therapeutics
Flerie Invest
Flerie Invest investment in Venture Round - Amarna Therapeutics
Pim Berger
Pim Berger investment in Venture Round - Amarna Therapeutics
Key Employee Changes
Official Site Inspections
http://www.amarnatherapeutics.com
- Host name: ip217-154-55-87.pbiaas.com
- IP address: 217.154.55.87
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Amarna Therapeutics"
About us - Amarna Therapeutics
Under his leadership, the organization grew to be a major player with approx. 9000 employees, at 30 facilities located in ten countries, offering pharmaceutical companies full service by taking …See details»
Home - Amarna Therapeutics
Amarna Therapeutics has developed a groundbreaking non-immunogenic viral platform to deliver any transgene of choice into humans. It is advancing a pipeline of transformative, potentially …See details»
Amarna Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Based on its unique properties SVac is ideally suited for developing next generation effective gene and …See details»
Amarna Therapeutics - LinkedIn
Feb 26, 2025 Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of both rare and prevalent diseases.See details»
Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Mar 6, 2025 Amarna is committed to pioneering treatments for Type 1 Diabetes Mellitus and enhancing patient outcomes. About NorthX Biologics NorthX Biologics, a leading …See details»
Amarna Therapeutics - Org Chart, Teams, Culture
View Amarna Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Amarna Therapeutics | Startup Profile and Investments
Amarna Therapeutics B.V. is a pioneering biotech company based in The Netherlands, founded in 2008.The company's focus lies in the development of transformative, potentially curative gene …See details»
Press Release - Amarna Therapeutics
Dec 1, 2021 The company is currently completing IND enabling studies and has initiated manufacturing with the aim of starting a Phase 1/2a trial in approximately two years. For this, …See details»
Amarna Therapeutics - Craft
Amarna Therapeutics has 5 employees at their 1 location and $11.02 m in total funding,. See insights on Amarna Therapeutics including office locations, competitors, revenue, financials, …See details»
Amarna Therapeutics - Overview, News & Similar companies
Amarna Therapeutics contact info: Phone number: +31 647566999 Website: www.amarnatherapeutics.com What does Amarna Therapeutics do? Amarna Therapeutics is …See details»
Amarna Therapeutics Company Overview, Contact Details
Amarna Therapeutics hired Henk Streefkerk as Chief Executive Officer and Medical Director on Jun 7th '23. Amarna Therapeutics, a privately held biotechnology company developing gene …See details»
Amarna Therapeutics announces appointment of Aurelia
Apr 19, 2024 E-mail: [email protected]. LifeSpring Life Sciences Communication, Amsterdam Léon Melens Tel: +31 6 538 16 427 E-mail: [email protected].See details»
Amarna Therapeutics - PitchBook
Amarna Therapeutics General Information Description. Operator of a biotechnology company intended to develop transformative, potentially curative gene therapies for a range of both rare …See details»
Amarna Therapeutics secures additional €5 ($5.7) million to …
Dec 1, 2021 For this, Amarna has recently engaged HALIX, a leading biopharmaceutical contract development and manufacturing organization (CDMO), to produce the clinical trial …See details»
Press Release - Amarna Therapeutics
Jan 11, 2022 Redoxis is a Swedish Clinical Research Organization (CRO) with core expertise and focus on preclinical drug development and efficacy evaluation in models of inflammatory …See details»
Amarna Therapeutics | VentureRadar
Website: http://www.amarnatherapeutics.com/ Develops transformative gene therapies using SV40-derived vectors for genetic disorders, autoimmune diseases, and chronic ...See details»
Amarna Therapeutics Partners with NorthX Biologics to
Dec 3, 2024 NorthX Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), has expertise in producing cell and gene therapies, …See details»
Amarna & NorthX Partner on Gene Therapy | NorthX Biologics
Dec 3, 2024 Amarna Therapeutics, a privately held biotechnology company specializing in transformative gene therapies, is pleased to announce its strategic collaboration with NorthX …See details»
Amarna Therapeutics - VentureRadar
Similar Companies: ReGenX Biosciences USA Publicly Traded REGENXBIO Inc. is the leading next-generation AAV gene therapy company, developing a new class of personalized …See details»
Amarna Therapeutics announces formation of Scientific Advisory …
Jun 17, 2024 Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvecâ„¢ AM510 gene therapy against Type 1 Diabetes …See details»